These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15357490)

  • 41. Mania during treatment of chronic hepatitis C with pegylated interferon and ribavirin.
    Onyike CU; Bonner JO; Lyketsos CG; Treisman GJ
    Am J Psychiatry; 2004 Mar; 161(3):429-35. PubMed ID: 14992966
    [No Abstract]   [Full Text] [Related]  

  • 42. Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C.
    Shiffman ML; Ghany MG; Morgan TR; Wright EC; Everson GT; Lindsay KL; Lok AS; Bonkovsky HL; Di Bisceglie AM; Lee WM; Dienstag JL; Gretch DR
    Gastroenterology; 2007 Jan; 132(1):103-12. PubMed ID: 17241864
    [TBL] [Abstract][Full Text] [Related]  

  • 43. "Maintenance" treatment for patients with cirrhosis related to hepatitis C.
    Gross JB
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):427-9. PubMed ID: 17445750
    [No Abstract]   [Full Text] [Related]  

  • 44. [Eliminating the gray zone. What can be done in normal ALT values?].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():75. PubMed ID: 15373059
    [No Abstract]   [Full Text] [Related]  

  • 45. Chronic hepatitis C and normal ALT: considerations for treatment.
    Bacon BR
    Am J Gastroenterol; 2004 Sep; 99(9):1706-7. PubMed ID: 15330906
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changing faces-natural course and treatment of hepatitis C after liver transplantation.
    Bahr MJ; Manns MP
    J Hepatol; 2004 Apr; 40(4):699-701. PubMed ID: 15030989
    [No Abstract]   [Full Text] [Related]  

  • 47. Hepatitis C with normal liver enzymes: to treat or not to treat. Con: most patients should not be treated.
    Reddy KR
    Am J Gastroenterol; 2004 Jun; 99(6):973-5. PubMed ID: 15180710
    [No Abstract]   [Full Text] [Related]  

  • 48. Hepatitis C with normal liver enzymes: to treat or not to treat. Pro: most patients should be treated.
    Koff JM; Younossi Z
    Am J Gastroenterol; 2004 Jun; 99(6):972-3. PubMed ID: 15180709
    [No Abstract]   [Full Text] [Related]  

  • 49. Long-term combined therapy with very-low-dose peginterferon and ursodeoxycholic acid decreased the spleen size in a patient with hepatitis C virus-related cirrhosis.
    Anzai T; Miyake Y; Yasuhara H; Miyatake H; Asagi A; Moriya A; Nakatsu M; Ando M; Hirohata M
    Intern Med; 2013; 52(3):363-7. PubMed ID: 23370746
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Chronic hepatitis C viral infection with persistent normal serum alanine aminotransferases].
    Huang CX; Bai XF
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):70-1. PubMed ID: 15670508
    [No Abstract]   [Full Text] [Related]  

  • 51. Controversies in the management of hepatitis C patients with advanced fibrosis and cirrhosis.
    Fontana RJ; Everson GT; Tuteja S; Vargas HE; Shiffman ML
    Clin Gastroenterol Hepatol; 2004 Mar; 2(3):183-97. PubMed ID: 15017601
    [No Abstract]   [Full Text] [Related]  

  • 52. [Acute hepatitis. Biological hepatic anomalies in asymptomatic persons].
    Buffet C
    Rev Prat; 2006 Sep; 56(13):1473-9; quiz 1479. PubMed ID: 17002075
    [No Abstract]   [Full Text] [Related]  

  • 53. Hepatic granulomas in chronic hepatitis C.
    Mert A; Tabak F; Ozaras R; Tahan V; Senturk H; Ozbay G
    J Clin Gastroenterol; 2001 Oct; 33(4):342-3. PubMed ID: 11588555
    [No Abstract]   [Full Text] [Related]  

  • 54. Antifibrogenic activity of interferon alpha in chronic hepatitis C.
    Suou T
    J Gastroenterol; 1999 Jun; 34(3):426-7. PubMed ID: 10433027
    [No Abstract]   [Full Text] [Related]  

  • 55. Should alanine aminotransferase flares mean stopping antiviral therapy in patients with cirrhosis?
    Vaillant A
    Lancet Infect Dis; 2019 Mar; 19(3):221-222. PubMed ID: 30833048
    [No Abstract]   [Full Text] [Related]  

  • 56. Persistently normal aminotransferase in chronic hepatitis C virus infection: is it time to redefine parameters of "normality"?
    Giannini E; Testa R
    Dig Liver Dis; 2001 Mar; 33(2):202-3. PubMed ID: 11346151
    [No Abstract]   [Full Text] [Related]  

  • 57. The Cost of Hepatitis C Testing Strategies in Primary Care Patients with Abnormal Transaminases.
    Schreiner AD; Rockey DC; Moran WP
    J Gen Intern Med; 2020 Apr; 35(4):1340-1342. PubMed ID: 31396811
    [No Abstract]   [Full Text] [Related]  

  • 58. Serum transaminase activity as an index of liver cell destruction.
    ARTURSON G; PERSSON BH
    Acta Chir Scand; 1959 Jul; 117():221-9. PubMed ID: 13794588
    [No Abstract]   [Full Text] [Related]  

  • 59. Transaminase values following open-heart surgery.
    QUINN JW; SIRAK HD; SHABANAH EH; FRAJOLA WJ
    Ann Surg; 1960 Jul; 152(1):45-50. PubMed ID: 14435567
    [No Abstract]   [Full Text] [Related]  

  • 60. [Moderate and prolonged increase of transaminases serum activity. Management].
    Capron JP
    Presse Med; 1989 May; 18(18):913-6. PubMed ID: 2524778
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.